Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo
- PMID: 12498010
Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo
Abstract
Pitavastatin (nisvastatin) is an HMG CoA reductase inhibitor being developed jointly by Nissan, Kowa Kogyo, Novartis and Sankyo for the potential treatment of atherosclerosis and hyperlipidemia.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources